Incannex Healthcare (IXHL) Common Equity (2020 - 2026)

Incannex Healthcare (IXHL) has reported Common Equity for 7 consecutive years, with $75.2 million the latest figure, recorded in Q1 2026.

• Quarterly Common Equity rose 916.26% year-over-year to $75.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $75.2 million (up 916.26% YoY) and the FY2025 annual result came in at $13.4 million, up 19.36% from the prior year.
• Common Equity grew to $75.2 million in Q1 2026 per IXHL's latest filing, from $73.4 million in the prior quarter.
• Over the last five years, Common Equity for IXHL reached as high as $77.0 million in Q3 2025 and fell as low as $964000.0 in Q4 2024.
• A 5-year average of $27.7 million and a median of $19.8 million in 2023 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2024 — Common Equity slumped 94.89% — and 2025, when it jumped 7514.73%.
• Year by year, Common Equity stood at $27.9 million in 2022, then plunged by 32.39% to $18.9 million in 2023, then sank by 94.89% to $964000.0 in 2024, then soared by 7514.73% to $73.4 million in 2025, then increased by 2.49% to $75.2 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $75.2 million, $73.4 million, and $77.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.